The glucose-analogue 2-deoxyglucose (2-DG) impedes cancer progression in animal models and is currently being assessed as an anti-cancer therapy. Yet, the mode of action of this drug of high clinical significance has not been fully delineated. In an attempt to better characterize its pharmacodynamics, an integrative UPLC-Q-Exactive based joint metabolomic and lipidomic approach was undertaken to evaluate the metabolic perturbations induced by this drug in human
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To the best of our knowledge, no metabolomic approaches were dedicated to unraveling the promising cytotoxicity of 2-DG. Metabolomics, i.e the global assessment of metabolites in a biological sample, represent the 'sharp end' of systems biology, encompassing the up-stream interactions between the genome, transcriptome, and proteome. 28 Metabolomic strategies were implemented to a variety of human studies and pinpointed several biomarkers of various diseases either to be applied to early diagnosis or to monitor responses to treatments. [29] [30] [31] [32] Metabolomes are extremely complex systems owing to the highly different physicochemical properties of metabolites. As unbiased approaches, metabolomic studies should not exclude metabolite classes and might rely on analytical techniques possessing high selectivity and sensitivity. 33 In order to separate the hydro soluble fraction and the hydrophobic phase, different extraction procedures can be assessed. Lipids of all major classes are known to be recovered via chloroform/methanol extraction systems. [34] [35] [36] With the introduction of the liquid-liquid Methyl tert-Butyl Ether (MTBE) extractions in lipidomics, 37 one can consider that the use of such systems can provide similar or better recovery rates of all major classes of lipids while ensuring faster and cleaner recoveries compared to previous benchmark methods. 38 Consequently, in our work, prior to undertaking large scale metabolomic studies, different extraction schemes were compared differing by the nature of both the quenching and organic solvents (either MeOH or MeOH/H 2 O (4/1, v/v) and MTBE or CHCl 3 , respectively). Untargeted LC-HRMS based strategies were also used since they represent the prevalent strategy to detect a wide range of chemical classes and thereby grant as broad a picture of metabolism as achievable. 39 As for related omics, metabolomic workflow generates thousands of data points among which only a tiny proportion might hold meaningful elements with mechanistic or explanatory power, so that relevant chemometric and statistical tools are mandatory to handle such large data sets. 40 In an attempt to assess the metabolic alterations triggered upon exposure to 2-DG, a UHPLC-HRMS based untargeted metabolomic approach was designed. The main aim of this investigation was to delineate the molecular mechanisms underlying the effects of 2-DG on human HaCaT keratinocytes, as we previously reported on transcriptomic alterations occurring upon 2-DG exposure on this cell line. 23 To get the widest possible insight, lipidomic and metabolomic analyses of extracellular and endocellular extracts were undertaken, both in positive and negative-ion modes. Subsequently, R-XCMS data processing, multivariate pattern recognition, metabolites identification and pathway analyses were delineated in the presence and absence of treatment by this drug. To the best of our knowledge, this study represents the first metabolomic investigation dedicated at studying the effects of 2-DG. Cell culture. Human keratinocyte cell line (HaCaT) was cultured as previously described. 41 To exclude any problem of senescence or drift of the cellular population, the experiments on keratinocytes were conducted at earlier passages (between 4 and 10). A strict control of cell growth for subsequent normalization of metabolic profiles according to cell number is mandatory to enable cross-sample comparisons. Protein assessment was here chosen
as an indicator of cell amount. 42 For metabolomic studies, cells (seeded at a density of 60 000 cells/cm 2 ) were transferred to six-well plates for 2 days. Then, cells were either directly processed or treated with 2-DG dissolved in water to reach a final concentration of 20 mmol/L, 6 for 3 h 23 , before quenching and metabolites extraction. This treatment was previously shown to induce a deep modification of gene expression. 23 To control 2-DG efficiency, the total amount of ATP was evaluated from wells treated in the same conditions using an ATP Bioluminescence Assay kit (Roche, Indianapolis, IN, USA). For normalization, total protein concentration was assessed in parallel using a Bio-Rad DC protein assay kit (Hercules, CA, USA), and total amount of ERK protein was evaluated by western blotting using anti-ERK1 (K-23) antibody (Santa Cruz Biotechnology, Dallas, Texas, USA). 43 Real Time PCR analyses on ER-chaperons, BIP and ORP150, were performed as previously described. 41 Analyses were performed in triplicate and
Welch's two-sample t-test was used to compute p values between control and treated groups.
Quenching and Cell Recovery. Cell metabolism must be deactivated through the quenching of biochemical processes that might alter the metabolic profiles and yield misleading results. 44 Even though the trypsination and cell scraping in a buffer solution are considered as the main possible approaches to harvest adherently growing cells for metabolomic studies, 37 the trypsination treatment step is reported to damage cell membranes with possible metabolite leakages, 45 and can be thereby regarded as inadequate for metabolomics. 37 Six-well plates were thus taken out of the 37 °C incubator and immediately placed on ice during the whole workflow described below.
Extraction procedures and Sample Preparations.
The overall metabolome comprises the endo-metabolome (i.e metabolites present in the cells) and the exo-metabolome (i.e metabolites encountered in the extracellular medium). As metabolites are continuously exchanged between intra-and extracellular environments (owing to uptake of nutrients, excretion of metabolites…), these fluxes can be monitored in the spent medium composition. 46 In an attempt to deepen the coverage of metabolites, the performances of several extraction solvent systems were evaluated: 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60   7 further centrifuged at 12,000 g and 4 °C for 15 min. An overview of this pipeline is provided in Figure 1 . 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 10 lens radiofrequency, 50 AU. HRMS data were acquired in full-scan mode over the m/z range 65-975 at a resolving power of 35000 FWHM at m/z 200. The Automatic Gain Control (AGC target) was set at high dynamic range (5x10 5 ) with a maximum injection time of 100 ms.
Quality control. Each sample was analyzed 6 times in a randomized batch sequence.
Prior to each batch analysis, the mobile phase was run for 1.5 h, followed by six QC samples to enable proper column equilibration and conditioning. To monitor and overcome analytical drifts in UPLC-MS, quality control samples were injected at regular intervals during the experimental sequence (i.e every 8 samples), in line with published guidelines. 47 For each analysis, the ions that were detected during either the dead volume (<0.6 min) or the conditioning of the column (>26 min) were eliminated. Features were considered reproducible if their Coefficient of Variation (CV) among QC samples were below 30%, as suggested elsewhere. 48, 49 Adversely, features that did not respect this condition were removed from the data subset. To further assess the validity of the analytical strategy described herein and assist in retention time correction, external isotope-labeled metabolites were added after the extraction process as detailed earlier.
These standard metabolites were selected to encompass a wide range of polarities and chemical structures. Thus, their retention times span across the whole chromatogram. Internal standards (i.e endogenous metabolites added prior to sample extraction) were also included to track sample extraction efficiency.
Data processing. Raw data were processed using R-XCMS to help with the putative identification of potential biomarkers of exposure to 2-DG. XCMS workflow involves typical data processing steps including peak discrimination, peak filtering and peak alignment. This workflow generates a data matrix presented as a feature list comprising their integrated intensities (Extracted Ion Chromatogram peak area) along with the corresponding Fold Change (FC) and associated ANOVA p-values. 50 Final peak picking parameters were: prefilter=(c, average chromatographic signal/10), peak width =c(5,25), snthresh=6, mzdiff= 0.01, ppm= 15.
Alignment (bw = 9, minfrac= 0.66, minsamp= 4, mzwid= 0.008) and retention time correction Tentative identification of metabolites. The tentative identification of the metabolites of interest was carried out as follows. The exact masses of their monoisotopic molecular weight were tentatively identified against the Progenesis Metascope "Biomolecules" database, and the free online databases, including METLIN 51, 52 (http://metlin.scripps.edu) and HMDB 53, 54 (http://www.hmdb.ca/). Metabolite hits were searched for with a tolerance of ± 5 ppm for both these databases considering several possible monoisotopic masses for each feature of interest (protonated molecules, ion adducts…). For lipidomic sequences, LipidMaps online database 55 (University of California, San Diego, CA -www.lipidmaps.org) was also consulted to elect the most suitable markers, considering a maximum adopted mass accuracy error of ± 5 ppm.
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RESULTS AND DISCUSSION
Assessing the cellular effects of 2-DG. First of all, ATP concentration and expression levels of the mRNA of two ER-resident chaperons, BIP (immunoglobulin heavy-chain binding protein, also named HSPA5) and ORP150 (oxygen regulated protein 150 kDa, or HYOU1), were measured, following experimental procedures which some of us previously described. 56 The results depicted in Figure 2 These sample processing methods were attempted on three different control samples that were subsequently submitted to the previously described metabolomic workflow (i.e each sample analyzed 6 times, in a randomized sequence).
These different procedures were compared with respect to the number of detected features and proportions of ions with CV below 30%, with the results being collated in Table S1 . Regarding the number of detected features, all three approaches granted results that were consistent there Peak area and intensity repeatability for the isotope-labeled standards were considered with a threshold of 30% CV, following the widely admitted idea that ions displaying higher CV values might not represent fitting candidates when searching for biomarkers. 64 All isotopelabeled standards fulfilled these conditions, with CV among QC samples being constantly below 15% (Tables S2 and S3 for lipidomic and metabolomics sequences, respectively). Both these results underscored the reliability of the analytical strategy developed herein. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60   15 for these putatively dysregulated features led to retain 8 candidate ions as biomarkers of exposure to 2-DG, genuinely corresponding to 6 metabolites ( Figure 3 , Table 2 ) as two of these putative biomarkers were found to occur in both positive and negative-ionization modes (M791T825/M827T825 and M819T887/M855T887 (positive-ion mode/negative-ion mode). Table 2 . Features typed in blue were detected in positive-ion mode and those appearing in green arose in negative polarity.
Accurate mass measurements from these ions were primarily searched against the freely available database LipidMaps, leading to retrieve a list of potential identifications based on previously defined accurate mass error ranges. Further searches were then carried out on METLIN and HMDB to check whether further identifications could be retrieved but none of these databases led to propose other putative hits. All these dysregulated features could thus be identified as a ceramide and different glucosylceramides ( Table 2 ). The biomarker M589T713
could be identified as a Cer(36:1), with several putative structures differing in the length and unsaturation degrees of the side chains being possible, as listed in Table 2 . From a biological viewpoint, all these long-chain ceramides display similar pro-apoptotic and anti-proliferative effects. 67, 68 Ceramides permeabilize the mitochondrial outer membrane, initiating mitochondrialmediated apoptosis through the release of cytochrome c. 69 Besides this non-protein-mediated signal, a variety of downstream signals involving an array of specific targets also account for ceramide-mediated apoptosis or autophagy. These molecular effects were recently reviewed in the specific context of mammalian epidermidis cells. 70 Being widely encountered in nature, glucosylceramides are glycolipids bearing a hydrophilic head group sugar, D-glucose, and two hydrophobic aliphatic chains (typically 16 to 26 atoms long) that vary in both length and saturation. 71 Glycosylceramide synthases are indeed known to convert ceramides into nontoxic glucosylceramides tending to offer cell protection and priming various cell types for proliferation, [72] [73] [74] contributing to convey multi-drug resistance. 75, 76 Owing to these opposite effects, the Cer-to-GlcCer ratio appears to modulate cellular growth versus apoptosis and it was demonstrated that human HaCaT keratinocyte cells might favor ceramide to glucosylceramide conversion to overcome ceramide cytotoxic effects. 77 Among the 5 glucosylceramides identified as dysregulated in the course of this manuscript, two could be associated with a single hit, i.e M791T825/M827T825 (GlcCer (d18:0/22:0)) and M819T887/M855T887 (GlcCer (d18:0/24:0)).
Two glucosylceramide candidates might be responsible for the three remaining hits, preventing us from reaching an unambiguous structural assignment. Nevertheless, the current data enables determining the overall number of carbons and unsaturations of the side chains, granting a sum composition expressed as (total carbons : total double bonds), as suggested by current lipidomic guidelines. 78 As such, M743T538 could be related to the molecular formula GlcCer (36:1), M789T733 to GlcCer (40:1) and M853T820 to GlcCer (42:1). The two possible structures for these latter are provided in Table 2 . Regarding the biological function of glucosylceramides, their effects were not so far evidenced to depend on the constitution of the fatty acid side chains, not even being shown to vary according to the sum composition of these structures. 79 Thus, satisfying biological conclusions can be drawn from the biochemical data garnered herein on these biomarkers. Accordingly, in the current study, glucosylceramides were much more upregulated than the identified ceramide which displayed a moderate FC value of 2 ( Table 2 ). The metabolomic study reported herein seems to unveil that HaCaT keratinocyte cells implement a similar defense strategy. A possible way to validate this putative scenario would be to monitor the expression of these dysregulated features following different times of treatment with 2-DG.
One can indeed assume that these up-regulations might refer to a two-step process that would begin with an increase of ceramide to be subsequently counteracted by an increased production of glucosylceramides, as a cytoprotective mechanism. These lipidomic dysregulations are consistent with former studies that reported on the alteration of total levels and/or species Conversely, this cellular system also responded by a slight decrease in GlcCer derivatives. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 Table 2 . List of potential metabolite candidates dysregulated upon 2-DG treatment, assessed in both positive and negative lipidomic analyses. These putative identifications were obtained after a search in the LipidMaps database with a cutoff of ± 5 ppm. *HaC: acetic acid. Elemental compositions, theoretical masses and errors for these features are provided in Table S6 . 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47 Metabolomic HILIC-MS analyses of endocellular fractions. Irrespective of the ionization mode, PCA plots failed to reveal a clear cut separation when all m/z signals were used ( Figure S3 ). Nevertheless, when only plotting the significantly altered m/z values upon 2 DG exposure (i.e p-value < 0.05 and fold-change > 2 with CV among QC samples < 30%), PCA plots resulted in a satisfying discrimination in both ion modes ( Figure S4 ). As reported in Table   1 , this filtered data set corresponded to 95 and 30 features in positive and negative-ion modes, respectively. Data processing and analysis emphasized 7 molecular features as major contributors to the variance between treated and control cells (Figure 4 , Table 3 ). These metabolites of interest were tentatively identified against METLIN and HMDB databases which could lead to propose putative identifications for all 7 features. Among these ions, only one, M277T435/M289T441, indicated a clear-cut dysregulation between the two sample groups, as previously reported for lipidomic sequences (Figure 4 ). This metabolite could be tentatively identified as galactosylglycerol but the biological relevance of this dysregulation still remains to be determined. With respect to the six remaining features, multiple putative identifications could be retrieved from freely available databases. Overall, these hits could be identified as phosphatidylcholine or phosphatidylethanolamine derivatives (Tables 3 and S4 ). More precisely, three biomarkers M809T320/M821T328, M719T328 and M747T329 could be related to this former class of lipids. Conversely, M751T169 could be identified as a phosphatidylethanolamine derivative. Regarding the two last biomarkers highlighted throughout the lipidomic workflow, putative hits could be retrieved from both phosphatidylcholine and phosphatidylethanolamine series. Generated results were assessed by regards to their physicochemical properties. Taking into account LogP values could narrow down the identification possibilities for these metabolites leading to tentatively identified them either as a phosphatidylethanolamine or a phosphatidylcholine derivative (Table S5) . As to M719T191, LogP values associated with the phosphatidylcholine candidates are not in line with the retention time obtained for this feature.
RT
Likewise, phosphatidylethanolamine candidates proposed for M761T326/M795T331 are too apolar to fit the retention time of this feature. Therefore, it can be assumed that M719T191 might stand for a phosphatidylethanolamine derivative and that M761T326/M795T331 corresponds to a further phosphatidylcholine-derived metabolite. Altogether, these data can lead to define a list of possible biomarkers related to a single structural series for all dysregulated features. Even though the lack of these substances as commercially available standards precluded the individual identification of these metabolites, each feature could be associated with a global number of carbons for the two side chains as well as an overall number of unsaturations, as earlier described for ceramide and glucosylceramide derivatives ( Table 3 ). The close physicochemical properties and identical matrices of occurrence precluded unambiguous structural assignments among the 20 remaining candidates. Further HRMS² analyses might be relevant to further discriminate between the possible candidates garnered in Table 3 even though reaching unambiguous structural assignments might be very hard to achieve, owing to the multiple possible positions of unsaturations, in particular. Not being able to discriminate among putative glycerophospholipids displaying an identical number of carbons and unsaturations is not believed to represent a severe limitation of the current work. Indeed, phosphatidylcholines represent a highly complex family of 1,2-diacylglycerophospholipids, that are mainly known through their structural role as essential components of cell membranes. These metabolites have in common a zwitterionic structure comprising hydrophobic side chains differing in their lengths and unsaturation degrees.
So far, the biological role of these glycerophospholipids has been primarily defined by regards to the overall chain length and not an individual molecule basis. 84 Accordingly, metabolomic investigations reporting on perturbations of glycerophospholipid content often define the global number of carbons and number of double bonds, as performed here. [85] [86] [87] As to the dysregulated phosphatidylethanolamine derivatives, it is worth noting that they display an identical number of carbons and unsaturations than phosphatidylcholine derivatives emphasized herein. Therefore, the former might represent biosynthetic intermediates en route to the latter. 88 Moreover, the level of these phosphatidylcholine and phosphatidylethanolamine derivatives are only poorly altered after 2-DG treatment with FC being always comprised between 2 and 3, so these effects might not be of paramount importance to understand the effects of this cytotoxic drug, further limiting the interest of reaching an unambiguous structural assignment of these features. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 Table 3 . List of potential metabolite candidates dysregulated upon 2-DG treatment, assessed in both positive and negative metabolomic analyses. These putative identifications were obtained after a search in the HMDB database with a cutoff of ± 5 ppm. Associated FC and ANOVA p-values are provided in Table 2 .*HMDB hits indicated between brackets display inconsistent physicochemical parameters (Table S5 ). **Owing to the elevated number of candidates, the exact references of hits along with the associated HMDB IDs are collated in Table S4 . Elemental compositions, theoretical masses and errors for these features are provided in Table S7 . Table 3 . Features typed in blue were detected in positive-ion mode and those appearing in green arose in negative polarity.
CONCLUSION
The analytical strategy described herein streamlined the delineation of 13 features (6 lipids and 7 metabolites) as biomarkers of acute exposure to 2-DG, thereby proving the adequacy of the proposed workflow for metabolomics. Lipidomic analyses unveiled that 2-DG mainly altered the metabolism of a ceramide, the moderate elevation of this pro-apoptotic lipid being accompanied by a dramatic increase of the concentration of the pro-mitogenic glucosylceramides, which might be interpreted as a cytoprotective mechanism to circumvent the cytotoxicity of the former. These 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 23 reach a single tentative candidate in cases where several hits were retrieved from databases. 
SUPPORTING INFORMATION
The following files are available free of charge at ACS website http://pubs.acs.org: Figure S1 . PCA plots obtained from endocellular lipidomics sequences from the whole set of features. Figure S2 . PCA plots obtained from endocellular lipidomics sequences using a filtered data set (features having both fold-change > 2, p-value < 0.05 and CV QC < 30%). Figure S3 .
PCA plots obtained from endocellular metabolomics sequences from the whole set of features. Figure S4 . PCA plots obtained from endocellular lipidomics sequences from filtered data set (features having both fold-change > 2, p-value < 0.05 and CV QC < 30%). Table S1 .
Comparison of extraction procedures involving several solvent systems (R-XCMS data processing). Table S2 . CV values of internal and external standards among QC samples in lipidomic sequences. Table S3 . CV values of internal and external standards among QC samples in metabolomic sequences. Table S4 . Tentative identification of metabolites dysregulated upon 2-DG treatment. Table S5 . Theoretical LogP values of putative metabolites identified during metabolomic sequences. Red-typed values are not consistent with the retention time of the feature. Table S6 . Summary of the data from the 8 features found significant in the comparisons 2-DG vs Sham-exposed sample groups (lipidomics). Table S7 . Summary of the data from the 8 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60   29 For TOC only 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57 58 59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57 58 59 Table 2 . Features typed in blue were detected in positive-ion mode and those appearing in green arose in negative polarity. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57 58 59 Figure 4 Box and whisker plots of the candidate biomarkers of challenge to 2-DG revealed by metabolomic HILIC analyses (n = 6). Features are designated as MXXXTYYY with XXX being the monoisotopic mass and YYY the retention time of the ion. Associated FC and ANOVA p-values are provided in Table 3 . Features typed in blue were detected in positive-ion mode and those appearing in green arose in negative polarity. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 
